Colibri has treated the first two patients in a feasibility study and cites Edwards Lifesciences as its main competition in the TAVR market.
FDA gave the company the green light to end a trial of its LAP-BAND System early, saving the company more than $5 million.
FDA Commissioner Scott Gottlieb updated the public regarding the agency's ongoing post-market review of the controversial birth control device, but patient advocacy group Essure Problems says the commissioner's words are just another letdown.
Spinal implant manufacturers have to be able to spot gaps where products are underutilized and need evidence-supported arguments along with value propositions to be successful in the market place.
Investors ranging from Google's parent company to pharma giants Novartis and AstraZeneca have shown interest in Rani Therapeutics, which is developing an ingestible drug-delivery pill.
FDA approved a new clinician programmer for the company's implantable pain pump, as well as a series of recent design changes aimed at improving the pump s a pain management device.
The company enrolled the first patient in a postmarket study of its Evolve workflow therapy to standardize guidance for physicians.
Through the process of electrochemical etching, researchers created a nanotextured material for stainless steel surfaces that can kill bacteria without harming cells.
Unlike traditional DBS systems that are built from pacemaker technology, this device is modeled from cochlear implant technology and the precise stimulation of auditory nerves it uses to replicate hearing.
A team of researchers are working on an implantable device that would communicate with an external control module and glasses.
A Chicago startup that seeks to 3-D print human hearts for transplantation has added to its scientific advisory board of heavy hitters. But just how close is the company to producing its first viable heart?
FDA cleared Cianna Medical's Savi Scout reflector for breast cancer conservation surgery without restrictions on the length of time the implant can remain in the breast.
The company now has CE mark for its Intellis platform for both Spinal Cord Stimulation and Peripheral Nerve Stimulation as an aid in the management of certain types of chronic pain.
The Gore Excluder AAA Endoprosthesis, used to seal off abdominal aortic aneurysms, launched in Europe 20 years ago. Find out how the product has evolved over the past two decades.